Back to Search
Start Over
Blood lactate level during extracorporeal life support as a surrogate marker for survival.
- Source :
-
The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2014 Aug; Vol. 148 (2), pp. 714-20. Date of Electronic Publication: 2014 Mar 02. - Publication Year :
- 2014
-
Abstract
- Objective: The establishment of reliable markers to monitor adequate tissue perfusion during extracorporeal life support is clinically important to improve outcomes.<br />Methods: We evaluated 115 consecutive adult patients (aged 61.7 ± 13.4 years, 59 female patients) undergoing extracorporeal life support to manage low cardiac output syndrome after major cardiac surgery. The blood lactate levels serially measured during extracorporeal life support (at 6, 12, and 24 hours) were analyzed.<br />Results: Forty-seven patients (40.8%) were weaned off extracorporeal life support successfully, and 32 patients (27.8%) survived to discharge. On logistic regression analysis, a high blood lactate level before extracorporeal life support (relative risk [RR], 1.19; 95% confidence interval [CI], 1.06-1.34) and cardiopulmonary bypass weaning failure after surgery (RR, 4.39; 95% CI, 1.44-13.35) emerged as baseline risk factors of mortality. After adjustment with these factors, blood lactate levels at 6 hours (RR, 1.24; 95% CI, 1.06-1.46), 12 hours (RR, 1.35; 95% CI, 1.10-1.67), and 24 hours (RR, 1.46; 95% CI, 1.10-1.93) were predictive of mortality. When the predictive values of serial blood lactate levels for mortality were assessed using the receiver operating characteristic method, the greatest accuracy was obtained at cutoff values of 7.05 mmol/L at 6 hours (sensitivity, 75.5%; specificity, 75.0%), 4.95 mmol/L at 12 hours (sensitivity, 70.4%; specificity, 76%), and 4.15 mmol/L at 24 hours (sensitivity, 62%; specificity, 93.1%).<br />Conclusions: Blood lactate measurement can be used as a reliable tool for monitoring adequate tissue perfusion during extracorporeal life support and was strongly predictive of mortality. Therefore, in patients without adequate decrement in lactate levels during extracorporeal life support, potential factors responsible for inadequate perfusion should be identified and corrected.<br /> (Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.)
- Subjects :
- Adult
Aged
Area Under Curve
Biomarkers blood
Cardiac Output, Low blood
Cardiac Output, Low diagnosis
Cardiac Output, Low mortality
Cardiac Surgical Procedures mortality
Chi-Square Distribution
Female
Hospital Mortality
Humans
Logistic Models
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Patient Discharge
Predictive Value of Tests
ROC Curve
Retrospective Studies
Risk Factors
Time Factors
Treatment Outcome
Cardiac Output, Low therapy
Cardiac Surgical Procedures adverse effects
Extracorporeal Membrane Oxygenation adverse effects
Extracorporeal Membrane Oxygenation mortality
Lactic Acid blood
Subjects
Details
- Language :
- English
- ISSN :
- 1097-685X
- Volume :
- 148
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- The Journal of thoracic and cardiovascular surgery
- Publication Type :
- Academic Journal
- Accession number :
- 24685378
- Full Text :
- https://doi.org/10.1016/j.jtcvs.2014.02.078